Innovation Pharmaceuticals Inc (IPIX)

[Scottwny]

Anyone else excited for a K update? Trial started 2/10. 3 weeks of treatment plus 3 week follow up.

Dr. B-
“This will be a small trial that will move quickly with the end goal to provide the critical data necessary to forge a partnership with a large pharmaceutical company interested in co-developing Kevetrin as it makes progress toward possibly becoming the first p53-activating drug approved by the FDA.”

PR quote-
"Cellceutix believes that this clinical trial, using IV dosing, will directly inform how Kevetrin modulates the p53 signaling pathway—one of the key questions asked by multiple pharmaceutical companies we are engaged with under Confidential Disclosure Agreements."